Click image to enlarge
This kit provides assay-specific components for the quantitative determination of phospho-S6RP (Ser235/Ser236) in human, mouse, rat, and non-human primate whole cell lysates.
-
-
Specifications
-
-
Documentation
-
References
|
Application(s)
|
|
Phosphoproteins
,
Intracellular Signaling
|
|
|
Analyte(s)
|
|
S6RP
|
|
|
Species
|
|
Human, Non-human primate, Mouse, Rat
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO SECTOR S 600MM
|
|
|
Plate Type
|
|
96-well
|
|
|
Capture Antibody
|
|
Rabbit Polyclonal
|
|
|
Detection Antibody
|
|
Rabbit Polyclonal
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Kit Model
|
|
Whole Cell Lysate
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma.
|
|
|
|
Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.
|
|
|
|
Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response.
|
|
|
|
Weekly nab-rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial.
|
|
|
|
mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations.
|
|
|
|
|
View All
|
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters